Bifidobacterium regulates premature infant gut metabolites, reducing serum inflammatory factors: a randomised controlled trial
Authors:
- 13 September 2024
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 97 (3) , 1171-1182
Abstract
Background Analyse the effects of Bifidobacterium BB-12 on intestinal metabolites and serum inflammatory factors in premature infants. Methods 71 premature infants at gestational age of ≤32 weeks were randomly divided into the probiotic (n = 36) and control (n = 35) groups. Faecal and blood samples were collected from the two groups of premature infants at the 2nd and 4th week of life for intestinal metabolite detection and assessment of the level of the serum inflammatory markers TLR4, NF- κ B, IL-1β, and TNF- α. Results Compared to the control group, the probiotic group contained more amino acids, these elements were enriched on multiple amino acid metabolic pathways, and the probiotic group showed significantly lower levels of the serum inflammatory markers TLR4, NF-κB, IL-1β, and TNF-α. Finally, the probiotic group showed a lower incidence of feeding intolerance. Conclusions The administration of Bifidobacterium BB-12 is associated with increasing the levels of glutamine, glutamic acid, and kynurenine in the gut of premature infants, and associated with reducing the levels of TLR4 and NF-κB in the serum, further decreasing the secretion of the pro-inflammatory factors IL-1β and TNF-α, and alleviating systemic inflammatory reactions, thereby reducing the incidence of feeding intolerance. Impact 1. The use of Bifidobacterium BB-12 in premature infants can increase the levels of amino acids in the intestine. 2. Increases in Bifidobacterium BB-12 may decrease the serum levels of TLR4, NF-κB, IL-1β, and TNF-α. 3. Kynurenine may improve the prognosis of preterm infants by reducing inflammation. 4. Bifidobacterium BB-12 may improve the feeding tolerance of premature infants, thus reducing the incidence of feeding intolerance.Keywords
This publication has 40 references indexed in Scilit:
- Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infantsCell Host & Microbe, 2022
- The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartmentsMolecular Psychiatry, 2022
- The microbiota-gut-brain axis: Focus on the fundamental communication pathways2020
- The premature infant gut microbiome during the first 6 weeks of life differs based on gestational maturity at birthPediatric Research, 2018
- Analysis of selected aspects of inflammasome function in the monocytes from neonates born extremely and very prematurelyImmunobiology, 2018
- Gut microbiota, metabolites and host immunityNature Reviews Immunology, 2016
- Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trialThe Lancet, 2016
- Probiotics for prevention of necrotizing enterocolitis in preterm infantsEvidence-Based Child Health: A Cochrane Review Journal, 2014
- Roles of glutamine in neurotransmissionNeuron Glia Biology, 2010
- NF-kB: a crucial transcription factor for glial and neuronal cell functionTrends in Neurosciences, 1997